The Working Group will define the range of health products for advanced therapies that could be conducted in laboratory/ambulatory settings, and examine whether and how to impose regulatory control on premises where health products for advanced therapies are processed.
The appointment recognizes not only Prof. Lee's outstanding academic credentials but also his wealth of experience in public service over the years.